Canada markets close in 6 hours 5 minutes

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
As of 09:30AM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 1.99M
Enterprise Value 5.92M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.39
Price/Book (mrq)N/A
Enterprise Value/Revenue 10.08
Enterprise Value/EBITDA -1.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.29
52-Week Change 3-50.00%
S&P500 52-Week Change 325.01%
52 Week High 30.0600
52 Week Low 30.0100
50-Day Moving Average 30.0161
200-Day Moving Average 30.0298

Share Statistics

Avg Vol (3 month) 347.94k
Avg Vol (10 day) 38.7k
Shares Outstanding 5132.63M
Implied Shares Outstanding 6176.85M
Float 8112.79M
% Held by Insiders 114.68%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 4311
Short Ratio (Apr 15, 2024) 40.01
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Feb 15, 2024) 4827

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,778.31%

Management Effectiveness

Return on Assets (ttm)-83.91%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)587.09k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-96.20%
Gross Profit (ttm)N/A
EBITDA -2.57M
Net Income Avi to Common (ttm)-3.27M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.02k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.09M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.12
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)-1.84M
Levered Free Cash Flow (ttm)-943.17k